Abraham Ceesay, Chief Executive Officer at Rapport Therapeutics, Inc. (RAPP), sold 8,210 shares at $45.55 ($374K) on 2026-09-08, disclosed to the SEC on 2026-09-09.
Scheduled sale ($374k) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $45.55 | 7,141 | $325K | 86.9% |
| 2 | $46.01 | 1,069 | $49K | 13.1% |
| Total | $45.61 avg | 8,210 | $374K | 100% |
| Filing → |
| RAPP | SELL | 2026-08-12 | $2.4M | — | Filing → |
| RAPP | SELL | 2026-07-29 | $93K | — | Filing → |
| RAPP | SELL | 2026-07-15 | $328K | — | Filing → |